QTREX Quantum Ltd. — Form F-1
Filed July 21, 2026 · analyzed by the Registration Agent
F-1
— Neutral
significance 48/100
What the filing says
On February 5, 2026, QTREX sold warrants to Armistice Capital Master Fund Ltd. to purchase 6,785,715 ordinary shares at $0.70/share (exercisable 6 months post-issuance, 5-year term). Concurrently, QTREX amended Armistice's existing December 2023 warrants (originally 3,031,250 shares at $1.28/share) to reduce exercise price to $0.70, extend expiration to February 5, 2031, and revise terms. This F-1 registers resale of warrant shares. QTREX receives ~$4.75M gross proceeds only if warrants are exercised for cash; resale proceeds go entirely to Armistice. Company has $3.2M cash (actual) as of Dec 31, 2025.
Why this rating
Warrant structure is routine equity financing; $4.75M potential proceeds meaningful (89% of company's $5.3M asset base) but uncertain (contingent on exercise). Registration is administrative. Dilution moderate: 6.8M shares = 12% of current outstanding (55.7M). Going concern doubt disclosed; near-term cash sufficiency stated at 6 months only.
See more from July 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.